-
1
-
-
84874499711
-
-
World Health Organization. Geneva, Switzerland
-
World Health Organization. 2012. World malaria report 2012. World Health Organization. Geneva, Switzerland. http://www.who.int/malaria /publications/world-malaria-report-2012/en/.
-
(2012)
World Malaria Report 2012
-
-
World Health Organization1
-
2
-
-
84874002038
-
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: An integrated analysis of individual patient data from six randomized clinical trials
-
Duparc S, Borghini-Fuhrer I, Craft CJ, Arbe-Barnes S, Miller RM, Shin CS, Fleckenstein L. 2013. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Malar J 12:70. http://dx.doi .org/10.1186/1475-2875-12-70.
-
(2013)
Malar J
, vol.12
, pp. 70
-
-
Duparc, S.1
Borghini-Fuhrer, I.2
Craft, C.J.3
Arbe-Barnes, S.4
Miller, R.M.5
Shin, C.S.6
Fleckenstein, L.7
-
5
-
-
84920155569
-
-
Geneva, Switzerland
-
nd ed. World Health Organization. Geneva, Switzerland. http: //whqlibdoc.who.int/publications/2010/9789241547925-eng.pdf.
-
-
-
World Health Organization1
-
6
-
-
84899468364
-
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine
-
Galappaththy GNL, Tharyan P, Kirubakaran R. 2013. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database Syst Rev 10:CD004389. http://dx.doi .org/10.1002/14651858.CD004389.pub3.
-
(2013)
Cochrane Database Syst Rev
, vol.10
, pp. CD004389
-
-
Galappaththy, G.N.L.1
Tharyan, P.2
Kirubakaran, R.3
-
7
-
-
84870283307
-
Primaquine for reducing Plasmodium falciparum transmission
-
Graves PM, Gelband H, Garner P. 2012. Primaquine for reducing Plasmodium falciparum transmission. Cochrane Database Syst Rev 9:CD008152. http://dx.doi.org/10.1002/14651858.CD008152.pub3.
-
(2012)
Cochrane Database Syst Rev
, vol.9
, pp. CD008152
-
-
Graves, P.M.1
Gelband, H.2
Garner, P.3
-
8
-
-
7644226738
-
Primaquine therapy for malaria
-
Baird JK, Hoffman SL. 2004. Primaquine therapy for malaria. Clin Infect Dis 39:1336-1345. http://dx.doi.org/10.1086/424663.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 1336-1345
-
-
Baird, J.K.1
Hoffman, S.L.2
-
10
-
-
0027535695
-
Interactions among primaquine, malaria infection and other antimalarials in Thai subjects
-
Edwards G, McGrath CS, Ward SA, Suparananond W, Pukrittayakamee S, Davis TM, White NJ. 1993. Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. Br J Clin Pharmacol 35:193-198. http://dx.doi.org/10.1111/j.1365-2125.1993.tb05685.x.
-
(1993)
Br J Clin Pharmacol
, vol.35
, pp. 193-198
-
-
Edwards, G.1
McGrath, C.S.2
Ward, S.A.3
Suparananond, W.4
Pukrittayakamee, S.5
Davis, T.M.6
White, N.J.7
-
11
-
-
33646932926
-
Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?
-
Cuong BT, Binh VQ, Dai B, Duy DN, Lovell CM, Rickman KH, Edstein MD. 2006. Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? Br J Clin Pharmacol 61:682-689. http://dx.doi.org/10.1111/j.1365-2125.2006.02601.x.
-
(2006)
Br J Clin Pharmacol
, vol.61
, pp. 682-689
-
-
Cuong, B.T.1
Binh, V.Q.2
Dai, B.3
Duy, D.N.4
Lovell, C.M.5
Rickman, K.H.6
Edstein, M.D.7
-
12
-
-
33746038593
-
Lack of sex effect on the pharmacokinetics of primaquine
-
Elmes NJ, Bennett SM, Abdalla H, Carthew TL, Edstein MD. 2006. Lack of sex effect on the pharmacokinetics of primaquine. Am J Trop Med Hyg 74:951-952.
-
(2006)
Am J Trop Med Hyg
, vol.74
, pp. 951-952
-
-
Elmes, N.J.1
Bennett, S.M.2
Abdalla, H.3
Carthew, T.L.4
Edstein, M.D.5
-
13
-
-
0032781772
-
Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in oxidative deamination of primaquine to carboxyprimaquine
-
Constantino L, Paixão P, Moreira R, Portela MJ, Do Rosario VE, Iley J. 1999. Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in oxidative deamination of primaquine to carboxyprimaquine. Exp Toxicol Pathol 51:299-303. http://dx.doi.org/10.1016/S0940-2993(99)80010-4.
-
(1999)
Exp Toxicol Pathol
, vol.51
, pp. 299-303
-
-
Constantino, L.1
Paixão, P.2
Moreira, R.3
Portela, M.J.4
Do Rosario, V.E.5
Iley, J.6
-
14
-
-
84864473749
-
CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine
-
Pybus BS, Sousa JC, Jin X, Christian RE, Barnhart R, Vuong C, Sciotti RJ, Reichard GA, Kozar MP, Walker LA, Ohrt C, Melendez V. 2012. CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. Malar J 11:259. http://dx.doi.org/10.1186/1475-2875-11-259.
-
(2012)
Malar J
, vol.11
, pp. 259
-
-
Pybus, B.S.1
Sousa, J.C.2
Jin, X.3
Christian, R.E.4
Barnhart, R.5
Vuong, C.6
Sciotti, R.J.7
Reichard, G.A.8
Kozar, M.P.9
Walker, L.A.10
Ohrt, C.11
Melendez, V.12
-
15
-
-
84879082233
-
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
-
Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, Caridha D, Zeng Q, Reichard GA, Ockenhouse C, Bennett J, Walker LA, Ohrt C, Melendez V. 2013. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Malar J 12:212. http://dx.doi.org/10.1186/1475 -2875-12-212.
-
(2013)
Malar J
, vol.12
, pp. 212
-
-
Pybus, B.S.1
Marcsisin, S.R.2
Jin, X.3
Deye, G.4
Sousa, J.C.5
Li, Q.6
Caridha, D.7
Zeng, Q.8
Reichard, G.A.9
Ockenhouse, C.10
Bennett, J.11
Walker, L.A.12
Ohrt, C.13
Melendez, V.14
-
16
-
-
84892772506
-
An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model
-
Jin X, Pybus BS, Marcsisin SR, Logan T, Luong TL, Sousa J, Matlock N, Collazo V, Asher C, Carroll D, Olmeda R, Walker LA, Kozar MP, Melendez V. 2014. An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model. Eur J Drug Metab Pharmacokinet 39:139-146. http://dx.doi.org/10.1007/s13318-013-0139-8.
-
(2014)
Eur J Drug Metab Pharmacokinet
, vol.39
, pp. 139-146
-
-
Jin, X.1
Pybus, B.S.2
Marcsisin, S.R.3
Logan, T.4
Luong, T.L.5
Sousa, J.6
Matlock, N.7
Collazo, V.8
Asher, C.9
Carroll, D.10
Olmeda, R.11
Walker, L.A.12
Kozar, M.P.13
Melendez, V.14
-
17
-
-
84884924313
-
Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria
-
Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy WF, Deye G, Melendez V, Ockenhouse CF. 2013. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med 369: 1381-1382. http://dx.doi.org/10.1056/NEJMc1301936.
-
(2013)
N Engl J Med
, vol.369
, pp. 1381-1382
-
-
Bennett, J.W.1
Pybus, B.S.2
Yadava, A.3
Tosh, D.4
Sousa, J.C.5
McCarthy, W.F.6
Deye, G.7
Melendez, V.8
Ockenhouse, C.F.9
-
18
-
-
60549099364
-
Primaquine revisited six decades after its discovery
-
Vale N, Moreira R, Gomes P. 2009. Primaquine revisited six decades after its discovery. Eur J Med Chem 44:937-953. http://dx.doi.org/10.1016/j .ejmech.2008.08.011.
-
(2009)
Eur J Med Chem
, vol.44
, pp. 937-953
-
-
Vale, N.1
Moreira, R.2
Gomes, P.3
-
19
-
-
0033760106
-
Pharmacokinetics of artemisinin-type compounds
-
Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P. 2000. Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet 39:255-270. http://dx.doi.org/10.2165/00003088-200039040-00002.
-
(2000)
Clin Pharmacokinet
, vol.39
, pp. 255-270
-
-
Navaratnam, V.1
Mansor, S.M.2
Sit, N.W.3
Grace, J.4
Li, Q.5
Olliaro, P.6
-
20
-
-
0141483123
-
Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
-
Li XQ, Björkman AE, Andersson TB, Gustafsson L, Collen AE, Masimirembwa C. 2003. Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 59:429-442. http://dx.doi .org/10.1007/s00228-003-0636-9.
-
(2003)
Eur J Clin Pharmacol
, vol.59
, pp. 429-442
-
-
Li, X.Q.1
Björkman, A.E.2
Andersson, T.B.3
Gustafsson, L.4
Collen, A.E.5
Masimirembwa, C.6
-
21
-
-
0036707622
-
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases
-
Ilett KF, Ethell BT, Maggs JL, Davis TM, Batty KT, Burchell B, Binh TQ, Thu le TA, Hung NC, Pirmohamed M, Park BK, Edwards G. 2002. Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos 30:1005-1012. http://dx.doi.org/10.1124/dmd.30.9.1005.
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1005-1012
-
-
Ilett, K.F.1
Ethell, B.T.2
Maggs, J.L.3
Davis, T.M.4
Batty, K.T.5
Burchell, B.6
Binh, T.Q.7
Thu Le, T.A.8
Hung, N.C.9
Pirmohamed, M.10
Park, B.K.11
Edwards, G.12
-
22
-
-
0029866008
-
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand
-
Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Wernsdorfer WH. 1996. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg 54:205-209.
-
(1996)
Am J Trop Med Hyg
, vol.54
, pp. 205-209
-
-
Looareesuwan, S.1
Kyle, D.E.2
Viravan, C.3
Vanijanonta, S.4
Wilairatana, P.5
Wernsdorfer, W.H.6
-
23
-
-
0030069741
-
Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa
-
Ringwald P, Bickii J, Basco LK. 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347:24-28. http://dx.doi.org/10.1016/S0140-6736(96)91558-5.
-
(1996)
Lancet
, vol.347
, pp. 24-28
-
-
Ringwald, P.1
Bickii, J.2
Basco, L.K.3
-
24
-
-
0031893366
-
Efficacy of oral pyronaridine for the treatment of acute uncomplicated Plasmodium falciparum malaria in African children
-
Ringwald P, Bickii J, Basco LK. 1998. Efficacy of oral pyronaridine for the treatment of acute uncomplicated Plasmodium falciparum malaria in African children. Clin Infect Dis 26:946-953. http://dx.doi.org/10.1086 /513942.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 946-953
-
-
Ringwald, P.1
Bickii, J.2
Basco, L.K.3
-
25
-
-
0032997429
-
In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum
-
Ringwald P, Eboumbou ECM, Bickii J, Basco LK. 1999. In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum. Antimicrob Agents Chemother 43:1525-1527.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1525-1527
-
-
Ringwald, P.1
Eboumbou, E.C.M.2
Bickii, J.3
Basco, L.K.4
-
26
-
-
84864685075
-
Review of pyronaridine anti-malarial properties and product characteristics
-
Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC, Shin CS, Fleckenstein L, Borghini-Furhrer I, Rim HJ. 2012. Review of pyronaridine anti-malarial properties and product characteristics. Malar J 11:270. http://dx.doi.org /10.1186/1475-2875-11-270.
-
(2012)
Malar J
, vol.11
, pp. 270
-
-
Croft, S.L.1
Duparc, S.2
Arbe-Barnes, S.J.3
Craft, J.C.4
Shin, C.S.5
Fleckenstein, L.6
Borghini-Furhrer, I.7
Rim, H.J.8
-
27
-
-
84920172921
-
Division of AIDS table for grading the severity of adult and pediatric adverse events 2009
-
December 2004; clarification August 2009
-
National Institute of Allergy and Infectious Diseases. 2009. Division of AIDS table for grading the severity of adult and pediatric adverse events. 2009. Version 1.0, December 2004; clarification August 2009. http://rsc .tech-res.com/document/safetyandpharmacovigilance/table-for-grading -severity-of-adult-pediatric-adverse-events.pdf.
-
(2009)
Version 1.0
-
-
National Institute of Allergy and Infectious Diseases1
-
28
-
-
84859561800
-
Drugdrug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers
-
Morris CA, Lopez-Lazaro L, Jung D, Methaneethorn J, Duparc S, Borghini-Fuhrer I, Pokorny R, Shin CS, Fleckenstein L. 2012. Drugdrug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.AmJ Trop Med Hyg 86:489-495. http://dx.doi.org/10 .4269/ajtmh.2012.11-0558.
-
(2012)
Amj Trop Med Hyg
, vol.86
, pp. 489-495
-
-
Morris, C.A.1
Lopez-Lazaro, L.2
Jung, D.3
Methaneethorn, J.4
Duparc, S.5
Borghini-Fuhrer, I.6
Pokorny, R.7
Shin, C.S.8
Fleckenstein, L.9
-
29
-
-
70349595536
-
Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers
-
Navaratnam V, Ramanathan S, Wahab MS, Siew Hua G, Mansor SM, Kiechel JR, Vaillant M, Taylor WR, Olliaro P. 2009. Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers. Eur J Clin Pharmacol 65:809-821. http://dx.doi.org/10.1007/s00228-009-0656-1.
-
(2009)
Eur J Clin Pharmacol
, vol.65
, pp. 809-821
-
-
Navaratnam, V.1
Ramanathan, S.2
Wahab, M.S.3
Siew Hua, G.4
Mansor, S.M.5
Kiechel, J.R.6
Vaillant, M.7
Taylor, W.R.8
Olliaro, P.9
-
32
-
-
84903184313
-
Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN)
-
Lourens C, Lindegardh N, Barnes KI, Guerin PJ, Sibley CH, White NJ, Tarning J. 2014. Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN). Antimicrob Agents Chemother 58:3889-3894. http://dx.doi.org/10.1128/AAC.02362-14.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 3889-3894
-
-
Lourens, C.1
Lindegardh, N.2
Barnes, K.I.3
Guerin, P.J.4
Sibley, C.H.5
White, N.J.6
Tarning, J.7
-
33
-
-
56249128216
-
A liquid chromatographictandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma
-
Hanpithakpong W, Kamanikom B, Dondorp AM, Singhasivanon P, White NJ, Day NP, Lindegardh N. 2008. A liquid chromatographictandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 876:61-68. http://dx.doi.org/10.1016/j .jchromb.2008.10.018.
-
(2008)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.876
, pp. 61-68
-
-
Hanpithakpong, W.1
Kamanikom, B.2
Dondorp, A.M.3
Singhasivanon, P.4
White, N.J.5
Day, N.P.6
Lindegardh, N.7
-
35
-
-
80052673399
-
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscu-lar, oral or rectal administration
-
Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L. 2011. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscu-lar, oral or rectal administration. Malar J 10:253. http://dx.doi.org/10 .1186/1475-2875-10-253.
-
(2011)
Malar J
, vol.10
, pp. 253
-
-
Morris, C.A.1
Duparc, S.2
Borghini-Fuhrer, I.3
Jung, D.4
Shin, C.S.5
Fleckenstein, L.6
-
36
-
-
0021998680
-
Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size
-
Mihaly G, Ward S, Edwards G, Nicholl D, Orme M, Breckenridge A. 1985. Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol 19:745-750.
-
(1985)
Br J Clin Pharmacol
, vol.19
, pp. 745-750
-
-
Mihaly, G.1
Ward, S.2
Edwards, G.3
Nicholl, D.4
Orme, M.5
Breckenridge, A.6
-
37
-
-
84901280985
-
Pharmacokinetic interactions between primaquine and chloroquine
-
Pukrittayakamee S, Tarning J, Jittamala P, Charunwatthana P, Lawpoolsri S, Lee SJ, Hanpithakpong W, Hanboonkunupakarn B, Day NP, Ashley EA, White NJ. 2014. Pharmacokinetic interactions between primaquine and chloroquine. Antimicrob Agents Chemother 58:3354-3359. http://dx.doi.org/10.1128/AAC.02794-13.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 3354-3359
-
-
Pukrittayakamee, S.1
Tarning, J.2
Jittamala, P.3
Charunwatthana, P.4
Lawpoolsri, S.5
Lee, S.J.6
Hanpithakpong, W.7
Hanboonkunupakarn, B.8
Day, N.P.9
Ashley, E.A.10
White, N.J.11
-
38
-
-
84913593970
-
An open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult Thai subjects
-
29 September
-
Hanboonkunupakarn B, Ashley EA, Jittamala P, Tarning J, Pukrittayakamee S, Hanpithakpong W, Chotsiri P, Wattanakul T, Panapipat S, Lee SJ, Day NP, White NJ. 29 September 2014. An open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult Thai subjects. Antimicrob Agents Chemother http: //dx.doi.org/10.1128/AAC.03704-14.
-
(2014)
Antimicrob Agents Chemother
-
-
Hanboonkunupakarn, B.1
Ashley, E.A.2
Jittamala, P.3
Tarning, J.4
Pukrittayakamee, S.5
Hanpithakpong, W.6
Chotsiri, P.7
Wattanakul, T.8
Panapipat, S.9
Lee, S.J.10
Day, N.P.11
White, N.J.12
-
39
-
-
0345503737
-
Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine
-
Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL. 1955. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med 46:301-306.
-
(1955)
J Lab Clin Med
, vol.46
, pp. 301-306
-
-
Alving, A.S.1
Arnold, J.2
Hockwald, R.S.3
Clayman, C.B.4
Dern, R.J.5
Beutler, E.6
Flanagan, C.L.7
|